Knowledge hub

Knowledge hub
News

Insights from the Society of Biomolecular Imaging & Informatics (SBI2) Conference

One-Week Transition to Cloud Infrastructure for Biotech Companies
Large-scale machine learning workflows
Recent Successes in Phenotypic Drug Discovery and the Future of ML/AI Methods
Ardigen phenAID’s Multimodal Approach Improves MoA and Bioactivity Prediction When Applied to a HCS Dataset from a Big Pharma Company
High Content Screening: Redefining What Is Possible with Artificial Intelligence and Machine Learning
Immudex and Ardigen announce partnership
AI-Powered Breakthroughs in Antibody Optimization
Ardigen at BioIT2024
News

Highlights from the nf-core Hackathon at Ardigen’s Krakow Office

New Publication on Decoding Phenotypic Screening: A Collaborative Effort with Janssen Pharmaceutica and Jagiellonian University
Ardigen Appoints New CCO to Accelerate Growth Plans and Become the Top AI CRO Worldwide
The New Issue of the OncoDecalogue Series is Now Available to Download for Free
Ardigen and Selvita Now Offer Joint Cell Painting Services
Resounding Success of OncoActive Days 2023 
New Paper Released by Ardigen and Collaborators: Advances in AI – Powered Histological Evaluation of Crohn’s Disease and Ulcerative Colitis
Code Against Cancer’s “ONCOdecalogue of Emotions” Receives Acclaim at PTPO Conference
Ardigen Celebrates 8 Years of Innovation in AI Drug Discovery
  • Services
  • Technology
Social Media
United States

611 Gateway Boulevard
South San Francisco, CA 94080
USA
tel.+1 628 200 09 14

One Broadway, 14th Floor
Cambridge, MA 02142
USA
tel.+1 628 200 09 14

European Union

Sternbacha 1
30-394 Kraków
Poland
tel.+48 12 340 94 94